Top 20 companies to predominate bulk drug production by 58%.

The KPMA reported that the top 20 out of the total 355 pharmaceutical raw material production companies occupied 58.4% of the bulk drug production, showing a bipolar phenomenon in the bulk production.

The total production value of bulk drugs in 2004 accounted 751 billion won, about 22.19% up from the previous year of 614.6 billion won, the KPMA reported, such a remarkable growth of which...